Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the potential effect of NHS England’s Budget Impact Test on single-dose gene therapies.

No assessment has been made.

The Budget Impact Test is an integral part of the National Institute for Health and Care Excellence (NICE) evaluation process for new interventions, including gene therapies. It assesses the financial implications of introducing a new therapy by considering factors such as patient eligibility, treatment costs, and the impact on National Health Service resources. NICE undertakes a Budget Impact Test for each individual single-dose gene therapy as part of standard NICE process.